November 25th, 2014
Editor’s note: World AIDS Day, which is Monday, Dec. 1, serves as a reminder that while significant progress has been made in the global battle against HIV/AIDS, there is still much more to be done and we must recommit to the goal of Getting to Zero. Johnson & Johnson, driven by our purpose of caring, remains committed to the prevention, detection, education and treatment of HIV/AIDS. This blog post is the first in a series intended to provide a glimpse of these efforts and some of the individuals leading them.
When I attended my first International AIDS Conference in 2002, UNAIDS reported that fewer than 30,000 people in sub-Saharan Africa had benefited from antiretroviral drugs. Even treating one million people on the continent was unimaginable at that time.
Fast-forward 12 years to this year’s conference in Melbourne, Australia, where I learned nearly 14 million people living with HIV in low and middle-income countries are now being treated, according to the most recent UNAIDS report.
This is very promising news. However, not all the news is good. As we approach World AIDS Day we are reminded that there is more work to be done, especially for adolescents.